Position
Fidelity in Vor Biopharma Inc.
Back to the book · All holders of VOR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $877.6K$17.84 → $18.41
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.53M | $33M | — | — | — | 0.0% |
| Q1 2026 | 1.54M | $27.5M | $17.84 | $7.33M | −$12.9M | 0.0% |
| Q2 2026 | 4.93M | $90.8M | $18.41 | $877.6K | $62.5M | 0.0% |